A5011265052- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver Disease and Transplantation
- Aortic aneurysm repair treatments
- Renal and Vascular Pathologies
- Peripheral Artery Disease Management
- Cancer Mechanisms and Therapy
- Renal cell carcinoma treatment
- Radiomics and Machine Learning in Medical Imaging
- Aortic Disease and Treatment Approaches
- Lung Cancer Treatments and Mutations
- Organ Transplantation Techniques and Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- MRI in cancer diagnosis
- Hepatitis B Virus Studies
- Diabetic Foot Ulcer Assessment and Management
- Colorectal Cancer Treatments and Studies
- Liver physiology and pathology
- Vascular Procedures and Complications
- Hepatitis C virus research
- Cancer, Lipids, and Metabolism
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
Candiolo Cancer Institute
2023-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2024-2025
University of Turin
2025
Azienda Ospedaliera Universitaria Pisana
2012-2024
University Hospital Magdeburg
2023
Azienda Ospedaliero-Universitaria Careggi
2022-2023
University of Pisa
2011-2021
Ospedale Cisanello
2008-2019
Society of Interventional Radiology
2014
University Radiology
2008
Transcatheter arterial chemoembolisation (TACE) is the treatment of choice for intermediate stage hepatocellular carcinoma (HCC). Doxorubicin-loaded drug-eluting beads (DEB)-TACE expected to improve performance conventional TACE (cTACE). The aim this study was compare DEB-TACE with cTACE in terms time-to-tumour progression (TTP), adverse events (AEs), and 2-year survival. Patients were randomised one-to-one undergo or followed-up at least 2 years until death. repeated ‘on-demand’. We...
Hepatocellular carcinoma (HCC) arises in the context of cirrhosis and chronic hepatitis B virus (HBV) infections, diagnosis is often made at advanced stages. Because early-stage improves survival, guidelines recommend screening patients risk for HCC, such as with cirrhosis. However, adherence to programs suboptimal. In this review, we discuss value HCC provide practical guidance on patient selection methods. International concordantly cirrhosis, including HBV C infections or without...
To evaluate contrast material-enhanced ultrasonography (US) for depiction of endoleaks after endovascular abdominal aortic aneurysm repair (or [EVAR]) in patients with enlargement and no evidence endoleak.From November 1998 to February 2003, 112 underwent EVAR. At follow-up, duplex US biphasic multi-detector row computed tomographic (CT) angiography were performed. In 10 (group A), evident was observed, complications, at both CT US. Group A patients, men (mean age, 69.6 years +/- [standard...
TIPS with Expanded Polytetrafluoroethylene–Covered Stent: Results of an Italian Multicenter StudyClaudio Vignali1, Irene Bargellini1, Maurizio Grosso2, Giovanni Passalacqua3, Franco Maglione4, Fulvio Pedrazzini2, Pietro Filauri3, Raffaella Niola4, Roberto Cioni1 and Pasquale Petruzzi1Audio Available | Share
To retrospectively evaluate the clinical outcome of patients with hepatocellular carcinoma (HCC) who exceeded Milan criteria, underwent transarterial chemoembolization (TACE) before orthotopic liver transplantation (OLT), to determine value computed tomography (CT)-based tumor response TACE as a preoperative selection criterion for OLT.The study included 33 HCC criteria and OLT after TACE. Informed written consent was obtained OLT. Institutional review board approval not required. Tumor...
Abstract Background Using data collected in the prospective observational study CIRSE Registry for SIR-Spheres Therapy, present aimed at identifying predictors of adverse events (AEs) following transarterial radioembolization (TARE) with Yttrium-90 resin microspheres liver tumours. Methods We analysed 1027 patients enrolled between January 2015 and December 2017 followed up 24 months. Four hundred twenty-two hepatocellular carcinoma (HCC), 120 intrahepatic (ICC), 237 colorectal metastases...
Our purpose was to assess the impact of muscle quality on overall survival (OS) in patients with advanced HCC.